期刊文献+

紫杉醇对人绒癌细胞增殖及凋亡的影响 被引量:2

Effect of paclitaxel on proliferation and apoptosis of human choriocarcinoma cell line JEG-3
暂未订购
导出
摘要 目的研究紫杉醇(Paclitaxel)对绒癌细胞株JEG-3细胞凋亡率和细胞周期的影响。方法用紫杉醇作用于绒癌细胞株JEG-3细胞,采用四甲基偶氮唑蓝(MTT)比色法观察紫杉醇对绒癌细胞增殖的影响,通过流式细胞仪分析紫杉醇处理后绒癌细胞凋亡率和细胞周期的改变。结果紫杉醇对绒癌细胞株JEG-3细胞的增殖具有抑制作用,且随药物浓度的增加和作用时间的延长,抑制作用越明显;紫杉醇对细胞凋亡率和细胞周期均有影响,随药物浓度增加和作用时间的延长,细胞凋亡率增加,G2/M期细胞百分率增加。结论紫杉醇能有效诱导绒癌JEG-3细胞的凋亡。 【Objective】To explore apoptosis and cell cycle distribution of human choriocarcinoma cell line JEG-3 treated by paclitaxel. 【Methods】The effect of paclitaxel on the proliferation of human choriocarcinoma cell line JEG-3 was evaluated by MTT growth assay. The rate of apoptosis and the cell cycle distribution were analyzed by flow cytometry. 【Results】Paclitaxel could inhibit the proliferation of cell line JEG-3. The inhibition effects were concentration and time dependent. Paclitaxel could affect the apoptosis of cells and the cell cycle distribution. The rate of apoptosis and the percentage of G2/M cells increased as the concentration of paclitaxel increased and the action time was prolonged.【Conclusion】Paclitaxel can induce apoptosis of human choriocarcinoma cell line JEG-3.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第4期510-514,共5页 China Journal of Modern Medicine
关键词 紫杉醇 绒毛膜癌 凋亡 细胞周期 paclitaxel choriocarcinoma apoptosis cell cycle
  • 相关文献

参考文献4

二级参考文献28

  • 1张颖,向阳,任彤,万希润,杨秀玉.恶性滋养细胞肿瘤肺转移患者肺叶切除术指征的探讨[J].中华妇产科杂志,2005,40(2):83-86. 被引量:13
  • 2孙崟,向阳,万希润,杨秀玉.绒毛膜癌复发的影响因素分析[J].中华妇产科杂志,2006,41(5):329-332. 被引量:7
  • 3Wan X, Xiang Y, Yang X, et al. Efficacy of the FAEV regimen in the treatment of high risk, drug resistant gestafional trophoblastic tumour[ J]. J Reprod Med,2007,52:941-944.
  • 4Soper JT, Evans AC, Clarke-Pearson D, et al. Alternating weekly chemotherapy with etopsid cyclophosphamide vincristine for high-risk gestational trophoblastic disease[ J]. Obstet Gynecol, 1994, 83 : 113-117.
  • 5Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycine D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumours refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumours [J]. J Clin Oncol, 2000,18 : 854- 859.
  • 6Xiang Y, Sun Z, Wan X, et al. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor [ J ]. J Reprod Med,2004,49(6) :443-446.
  • 7Kohom EI, Goldstein DP, Hancock BW, et al. Combining the staging system of the international federation of gynecology and obstetrics with the scoring system of the world health organization for trophoblastic neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society [ J ]. Int J Gynecol Cancer, 2000,10 : 84-88.
  • 8Kohom EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease:description and critical assessment[J]. Int J Gynecol Cancer, 2001,11:73-77.
  • 9Ngan S, Seckl MJ. Gestational trophoblastic neoplasia management : an update[J]. Curr Opion Oncol,2007 ,19 :486-491.
  • 10Newlands ES, Bagshawe KD, Begent RHJ, et al. Results with EMA/CO ( etopside, methotrexate, actinomycin, cyclophosphamide and vincristine ) regimen in high-risk gestational trophoblastic tumours, 1970 to 1989[J]. Br J Obstet Gynecol, 1991, 98:550-557.

共引文献23

同被引文献19

  • 1Matsui H, Iitsuka Y, Suzuka K, et al. Salvage chemotherapy for high- risk gestational trophoblastic tumor [ J ]. J Reprod Med, 2004,49(6) :438 -442.
  • 2Allias F, Bolze PA, Gaillot - Durand L, et al. Gestational tropho- blastie disease [ J]. Ann Pathol,2014,34(6) :434-447.
  • 3Deng L, Zhang J, Wu T, et al. Combination chemotherapy for pri- mary treatment of high -risk gestatianal trophoblastie tumour [ J]. Coehrane Database Syst Rev, 2013, ( 1 ) :CD005196.
  • 4Goldstein DP, Berkowitz RS. Current management of gestational trophoblastie neoplasia [ J ]. Hematol Oneol Clin North Am, 2012,26(1) :111 - 131.
  • 5Froeling FE, Seekl MJ. Gestational trophoblastie tumours: an up- date for 2014 [J]. Curr Oneol Rep, 2014,16(11) :408.
  • 6Alazzam M, Tidy J, Osborne R, et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia [ J ]. Cochrane Da- tabase Syst Rev, 2012,12 : CD008891.
  • 7Fanzee NJ. Taxanes : promising anti - cancer drugs [ J ]. Asian Pac J Cancer Prey,2011,12 (4) : 837 - 851.
  • 8Lin Y, Jiang D, Li Y, et al. Effect of sun ginseng potentiation on epirubicin and paclitaxel - induced apoptosis in human cervi- cal cancercells [ J ]. J Ginseng Res, 2015,39 ( 1 ) :22 - 28.
  • 9Jones WB, Schneider J, Shapiro F, et al. Treatment of resistant gestational choriocarcinoma with taxol : a report of two cases [ J ]. Gynecol Oncol, 1996,61 ( 1 ) :126 - 130.
  • 10Koizumi W, Kim YH, Fujii M, et al. Addition of docetaxel to S - 1 without platinum prolongs survival of patients with advanced gastric cancer: arandomized study(START) [J]. J Cancer Res Clin Oncol, 2014,140(2) :319 -328.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部